TransMedics Group Earnings
NASDAQ: TMDXHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$0.27
TransMedics Group earnings summary
TransMedics Group is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.27. In its most recent report on Aug 4, 2026 (Q2 2026), TMDX posted EPS of $0.41. Revenue for the quarter was $189.9 million.
Quarterly EPS is down 55.4% from the same quarter a year earlier. Across the last 16 reports, TMDX shares moved an average of 8.1% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
TMDX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $0.41 | — | +5.6% |
| May 5, 2026 | — | $0.20 | — | -6.8% |
| Feb 24, 2026 | — | $2.59 | — | -10.8% |
| Oct 29, 2025 | — | $0.66 | — | -9.4% |
| Jul 30, 2025 | — | $0.92 | — | -5.0% |
| May 8, 2025 | — | $0.70 | — | +9.0% |
| Feb 27, 2025 | — | $0.19 | — | -11.6% |
| Oct 28, 2024 | — | $0.12 | — | +4.3% |
| Jul 31, 2024 | — | $0.35 | — | +8.5% |
| Apr 30, 2024 | — | $0.35 | — | +1.6% |
| Feb 26, 2024 | — | $0.12 | — | +1.2% |
| Nov 8, 2023 | — | $-0.78 | — | +19.7% |
| Aug 4, 2023 | — | $-0.03 | — | -19.5% |
| May 4, 2023 | — | $-0.08 | — | +2.2% |
| Feb 27, 2023 | — | $-0.19 | — | -13.1% |
| Nov 4, 2022 | — | $-0.25 | — | +0.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.